drugset / Trial / NCT01068158

A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects

NCT01068158

Phase 3 Completed 371 enrolled Topaz Pharmaceuticals Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if 0.5% Ivermectin Cream is a safe and effective treatment for head lice infestations.

Timeline

Start
2010-03
Primary completion
2010-06
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivermectin Small molecule 0.5 % Topical